News
SCNI
0.7138
+22.23%
0.1298
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga · 2d ago
Scinai Immunotherapeutics Raises $2.61 Million in ADS and Warrant Financing to Expand CDMO and Immunotherapy Programs
TipRanks · 2d ago
12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga · 2d ago
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga · 2d ago
Weekly Report: what happened at SCNI last week (0420-0424)?
Weekly Report · 3d ago
Why Organon Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket
Benzinga · 3d ago
Morning News Wrap-Up, 4/24/26: Today’s Biggest Stock Market Stories!
TipRanks · 5d ago
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga · 5d ago
Scinai Secure $2.61 Million In Private Placement To Advance CDMO Expansion; Stock Up
NASDAQ · 5d ago
Why Scinai Immunotherapeutics Stock Is Skyrocketing 90% Higher Today
Benzinga · 5d ago
Nasdaq Gains Over 100 Points; Intel Shares Jump After Strong Q1 Results
Benzinga · 5d ago
Why Is Scinai Immunotherapeutics Stock (SCNI) Up Today?
TipRanks · 5d ago
Scinai Immunotherapeutics skyrockets premarket on $2.61M private placement financing
Seeking Alpha · 5d ago
Scinai Immunotherapeutics announces $2.61M private placement
TipRanks · 5d ago
Scinai Immunotherapeutics Enters Securities Purchase Agreement For Up To 5.21M ADS And Warrants Priced At $0.48 Per Unit
Benzinga · 5d ago
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga · 5d ago
Scinai Immunotherapeutics Announces $2.61 Million Private Placement Financing
PR Newswire · 5d ago
Weekly Report: what happened at SCNI last week (0413-0417)?
Weekly Report · 04/20 09:06
Why TopBuild Shares Are Trading Higher By 20%; Here Are 20 Stocks Moving Premarket
Benzinga · 04/20 08:37
Weekly Report: what happened at SCNI last week (0406-0410)?
Weekly Report · 04/13 09:07
More
Webull provides a variety of real-time SCNI stock news. You can receive the latest news about Scinai Immunotherapeutics Ltd. through multiple platforms. This information may help you make smarter investment decisions.
About SCNI
Scinai Immunotherapeutics Ltd, formerly known as BiondVax Pharmaceuticals Ltd is an Israel-based biopharmaceutical company that is principally focused on developing, manufacturing, and commercializing medical products for the prevention and treatment of autoimmune and infectious diseases but also for other illnesses. The Company’s core focus is to develop NanoAbs for the treatment of various diseases such as COVID-19, psoriasis, and asthma. The Company's product NanoAb is based on alpaca-derived nanosized antibodies (NanoAbs), also known as VHH-antibodies. Additionally, the Company offers manufacturing facilities, aseptic fill and finish suites, laboratories, and experienced professionals for other research and development companies. Scinai Immunotherapeutics Ltd operates in Israel.